AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16409193
Drug: Grass allergen
RxNorm normalized name: orchardgrass allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grass allergen tablet (SQ-T)
Trial: 12744860
Drug: Acellular pertussis
RxNorm normalized name: Acellular pertussis vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular pertussis vaccine (5 doses)
Trial: 12744860
Drug: Whole‐cell pertussis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole‐cell pertussis vaccine (5 doses)
Trial: 10561296
Drug: Docetaxel 100
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 100 mg/m(2) every 3 weeks
Trial: 10561296
Drug: Doxorubicin 75
RxNorm normalized name: DOXOrubicin 75 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin 75 mg/m(2) every 3 weeks
Trial: 8739678
Drug: latanoprost 0.005%
RxNorm normalized name: LATANOPROST 0.005% SOLN,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: latanoprost 0.005% once daily (morning dose)
Trial: 8739678
Drug: latanoprost 0.005%
RxNorm normalized name: LATANOPROST 0.005% SOLN,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: latanoprost 0.005% once daily (evening dose)
Trial: 3529971
Drug: timolol 0.5%
RxNorm normalized name: Timolol 0.5% Ophthalmic Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: timolol 0.5% twice daily
Trial: 1820640
Drug: 7-day regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 7-day regimen of oral artesunate at 600 mg
Trial: 1820640
Drug: 5-day regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-day regimen of oral artesunate at 600 mg
Trial: 6755786
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) 325 mg and placebo
Trial: 6755786
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) and dipyridamole (DIP) 325 mg and 75 mg
Trial: 6755786
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) and dipyridamole (DIP)
Trial: 31361815
Drug: Supportive text
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive text messages (twice-daily) over 6 months
Trial: 31361815
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual for 6 months
Trial: 23102885
Drug: Thrombolysis group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolysis group (TG) - low-dose tissue plasminogen activator plus anticoagulation (n=61)
Trial: 22578727
Drug: Adjuvant androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant androgen deprivation therapy
Trial: 2827456
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran (30 g added to formula meal)
Trial: 28809383
Drug: Full-dose α-galactosidase
RxNorm normalized name: ALPHA-GALACTOSIDASE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose α-galactosidase (300 GALU)
Trial: 28809383
Drug: Half-dose α-galactosidase
RxNorm normalized name: ALPHA-GALACTOSIDASE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-dose α-galactosidase (150 GALU)
Trial: 28137316
Drug: time‐intensive cognitive‐behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: time‐intensive cognitive‐behaviour therapy (iCBT)
Trial: 25639732
Drug: Gestalt and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestalt and lucid dreaming group therapy (LDG)
Trial: 25639732
Drug: Gestalt therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestalt therapy group (GTG)
Trial: 18374458
Drug: Seal oil
RxNorm normalized name: seal oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seal oil (10 mL, 3 times a day for 14 days)
Trial: 18374458
Drug: Cod liver
RxNorm normalized name: Cod Liver Oil
DrugBank: Cod liver oil (DB11321)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cod liver oil (10 mL, 3 times a day for 14 days)
Trial: 16685542
Drug: Topical furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical furosemide (6.6 mmol/l solution)
Trial: 29210507
Drug: Iron and
RxNorm normalized name: beef,iron and wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron and folic acid syrup (IFAS) administered twice weekly for 1 month
Trial: 26875894
Drug: Argon plasma
RxNorm normalized name: argon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argon plasma coagulation combined high frequency electric knife therapy
Trial: 21872537
Drug: Personalized interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Personalized interventions developed using the Treatment Routes for Exploring Agitation decision tree protocol
Trial: 15965635
Drug: Spa therapy
RxNorm normalized name: Broda Acne Spa
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa therapy (n = 16) for 2 weeks in addition to medical treatment
Trial: 15965635
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n = 14) continued medical treatment and/or daily exercises
Trial: 15965635
Drug: Spa therapy
RxNorm normalized name: Broda Acne Spa
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa therapy (n = 16)
Trial: 11896092
Drug: 4 x
RxNorm normalized name: Mepilex AG 4 x 4"
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 x DOC (100 mg/m(2))
Trial: 10207925
Drug: Acetazolamide (ACZ)
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetazolamide (ACZ) and furosemide (FUR) treatment
Trial: 29110972
Drug: Dulaglutide 1.5
RxNorm normalized name: dulaglutide 1.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dulaglutide 1.5 mg added to insulin glargine
Trial: 29110972
Drug: Placebo added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo added to insulin glargine
Trial: 22020607
Drug: Epidural administration
RxNorm normalized name: epidural administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural administration of 10 mg of etanercept and 2.0 mL of lidocaine
Trial: 22020607
Drug: Epidural administration
RxNorm normalized name: epidural administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural administration of 3.3 mg of dexamethasone and 2.0 mL of lidocaine
Trial: 17761319
Drug: Active extracorporeal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active extracorporeal shockwave therapy (0.25 mJ/mm(2))
Trial: 17761319
Drug: Sham shockwave
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham shockwave therapy
Trial: 15066896
Drug: QI-meds and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QI-meds and QI-therapy
Trial: 8664455
Drug: Insulin (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin (1.5 U/kg/h)
Trial: 1972963
Drug: Sunflowerseed oil
RxNorm normalized name: Sunflowerseed oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunflowerseed oil (60 ml/day)
Trial: 1972963
Drug: Linseed oil
RxNorm normalized name: linseed oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linseed oil (60 ml/day)
Trial: 1972963
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil (60 ml/day)
Trial: 340006
Drug: Indoprofen 800
RxNorm normalized name: Neoprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indoprofen 800 mg/day
Trial: 369924
Drug: Indomethacin 80
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin 80 mg/day
Trial: 27003895
Drug: Single subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single subcutaneous injection of FE 999049 at doses of 37.5, 75, 150, 225, or 450 IU
Trial: 19278583
Drug: Ulinastatin and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ulinastatin and thymosin alpha1, 200 kU IV twice a day for 4 days, then 100 kU for 6 days; thymosin alpha1, 1.6 mg subcutaneous twice a day for 4 days, then 1.6 mg per day for 6 days.
Trial: 19278583
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received conventional treatment according to Surviving Sepsis Campaign (SSC) 2004.
Trial: 7935897
Drug: Group C
RxNorm normalized name: STREPTOCOCCUS ANTIGEN (GROUP C)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C (received a list with actual medication and recommendations by the pharmacist)
Trial: 7935897
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (control group, sent prescriptions as before)
Trial: 7935897
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (received a list with medication used by their patients)
Trial: 29246950
Drug: Exenatide ER
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide ER 2.0 mg
Trial: 27481188
Drug: Transarterial chemoembolization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transarterial chemoembolization (TACE) with bicarbonate local infusion
Trial: 27481188
Drug: Transarterial chemoembolization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transarterial chemoembolization (TACE) without bicarbonate local infusion
Trial: 24708031
Drug: Tiotropium plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium plus Indacaterol (combined therapy)
Trial: 23000116
Drug: Intervention (annual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention (annual prostate-specific antigen for 6 years and digital rectal exam for 4 years)
Trial: 20518086
Drug: Viusid (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viusid (3 sachets daily)
Trial: 15739653
Drug: UlcerCare leg
RxNorm normalized name: Crab leg
DrugBank: Crab leg (DB11011)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UlcerCare leg wrap (treatment)
Trial: 10614952
Drug: Intravenous ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ciprofloxacin 200 mg
Trial: 8157551
Drug: Intravenous ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ciprofloxacin 400 mg
Trial: 8157551
Drug: Oral ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ciprofloxacin 500 mg
Trial: 3529803
Drug: Sodium hyaluronate
RxNorm normalized name: sodium hyaluronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium hyaluronate (Healon) + 500 mg acetazolamide at the end of surgery (Group II)
Trial: 24505906
Drug: Local periprostatic
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local periprostatic anesthesia with 10 ml of lidocaine
Trial: 12955409
Drug: Intracoronary adenosine
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary adenosine doses >16 microg
Trial: 2402051
Drug: Formula without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula without supplements
Trial: 30940201
Drug: Postoperative analgesics
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative analgesics use
Trial: 28335624
Drug: Cognitive-Behavioral Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Behavioral Therapy (CBT) - 16 sessions of 50 minutes each
Trial: 28335624
Drug: Escitalopram -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram - 10-20 mg/day for 12 weeks
Trial: 28335624
Drug: Duloxetine -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine - 30-60 mg/day for 12 weeks
Trial: 26250060
Drug: Systemic amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic amoxicillin 500 mg plus metronidazole 400 mg (3x/day, 7 days)
Trial: 21707564
Drug: Patient-controlled analgesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled analgesia using remifentanil (25-30 μg per bolus)
Trial: 21707564
Drug: Intramuscular pethidine
RxNorm normalized name: pethidine
DrugBank: Meperidine (DB00454)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular pethidine (50-75 mg)
Trial: 16439428
Drug: Allopurinol (acute
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (acute administration)
Trial: 2851654
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of low sodium intake and enalapril
Trial: 31621255
Drug: Wrist-ankle needle
RxNorm normalized name: Bos taurus ankle joint preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wrist-ankle needle combined with opioid drugs
Trial: 28489798
Drug: Functional microarray
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional microarray of microneedles plus topical 0.5% tranexamic acid solution
Trial: 28489798
Drug: Sham device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham device plus topical 0.5% tranexamic acid solution
Trial: 24495682
Drug: Intradermal injection
RxNorm normalized name: Dryvax Intradermal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal injection group, administered via bilateral forearm intradermal injections for immunotherapy once every 21 days, measured after 2, 3, 4, and 5 times of injections.
Trial: 24495682
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection group, administered via subcutaneous injection once every 21 days, measured after 3 times.
Trial: 24495682
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups after blocking antibody turning positive.
Trial: 19205272
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (400 microg initial dose followed by up to 1200 microg if needed)
Trial: 19205272
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (400 microg initial dose followed by up to 1200 microg if needed)
Trial: 1433118
Drug: Ceftazidime (CAZ)
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftazidime (CAZ) monotherapy
Trial: 1433118
Drug: Aminoglycoside+(ureido)penicillin combination
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aminoglycoside+(ureido)penicillin combination (AG+PEN)
Trial: 25305763
Drug: Pulsed Dye
RxNorm normalized name: amaranth dye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed Dye Laser (PDL) plus topical propranolol
Trial: 11932272
Drug: Micronized E2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized E2 (2 mg/d) plus standard-dose alendronate (10 mg/d)
Trial: 11932272
Drug: Micronized E2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized E2 plus low-dose alendronate (5 mg/d)
Trial: 11932272
Drug: Micronized E2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized E2 plus placebo (one tablet per day)
Trial: 10374427
Drug: HpPro 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HpPro 7.5 mg orally three times daily
Trial: 10374427
Drug: Mixture of
RxNorm normalized name: OCTADECANOL (MIXTURE OF ISOMERS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixture of known drugs (control)
Trial: 50681
Drug: Placental gamma-globulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placental gamma-globulin administered at a dose of 3 ml
Trial: 22496329
Drug: OC000459 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OC000459 (200 mg twice daily)
Trial: 16882708
Drug: 20 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/m2 intravenously daily for 5 days
Trial: 16882708
Drug: 20 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/m2 subcutaneously daily for 5 days
Trial: 16882708
Drug: 10 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/m2 intravenously daily for 10 days
Trial: 16882708
Drug: 5-day intravenous
RxNorm normalized name: ketorolac
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-day intravenous schedule
Trial: 9449019
Drug: Alcohol 0.45
RxNorm normalized name: ALCOHOL 0.45 mL in 1 mL TOPICAL LIQUID [Decolorized Iodine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol 0.45 g/lbw
Trial: 9449019
Drug: Alcohol 0.15
RxNorm normalized name: benzyl alcohol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol 0.15 g/lbw
Trial: 9449019
Drug: Alcohol 0.30
RxNorm normalized name: ALCOHOL 0.30 mL in 1 mL TOPICAL LIQUID [Health and Beyond Green]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol 0.30 g/lbw
Trial: 11549204
Drug: Imidapril 10
RxNorm normalized name: imidapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidapril 10 mg
Trial: 8198936
Drug: Imidapril 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidapril 40 mg
Trial: 8198936
Drug: Imidapril 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidapril 2.5 mg
Trial: 3122546
Drug: Propranolol (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (up to 320 mg per day)
Trial: 3122546
Drug: Nifedipine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (up to 120 mg per day)
Trial: 3122546
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin therapy (control)
Trial: 24705022
Drug: ALICE app
RxNorm normalized name: Eyes Alive Lubricating
DrugBank: Carboxymethylcellulose (DB11059)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALICE app for patients with initially higher rate of medication errors
Trial: 24705022
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (oral and written information on safe medication use)
Trial: 22579007
Drug: AMC/DCBA +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMC/DCBA + lidocaine lozenge
Trial: 22579007
Drug: Hexylresorcinol lozenge
RxNorm normalized name: Hexylresorcinol Lozenges
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexylresorcinol lozenge
Trial: 18932286
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (TCM) therapy combined with Western medicine
Trial: 16211732
Drug: succinylcholine 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: succinylcholine 1.0 mg kg[‐1]
Trial: 16211732
Drug: rocuronium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rocuronium 0.6 mg kg[‐1]
Trial: 10818662
Drug: Treatment of
RxNorm normalized name: DRUGS FOR TREATMENT OF LEPRA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment of male partners of women with bacterial vaginosis
Trial: 24664539
Drug: Topical lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lidocaine (4%) pretreatment
Trial: 24664539
Drug: Oral tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tramadol (50-mg) pretreatment
Trial: 19072827
Drug: HCV796 (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCV796 (a selective nonstructural protein 5B polymerase inhibitor)
Trial: 19072827
Drug: HCV796 monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCV796 monotherapy
Trial: 19072827
Drug: HCV796 in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCV796 in combination with interferon (30 mg/kg three times per day)
Trial: 19072827
Drug: HCV796 in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCV796 in combination with pegylated interferon and ribavirin
Trial: 17393073
Drug: Triapine® (96
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triapine® (96 mg/m2 2‐h infusion daily for 4 days, repeated every 2 weeks)
Trial: 12825566
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg oxycodone
Trial: 8634808
Drug: 10% glycolic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% glycolic acid-based moisturizer (twice daily)
Trial: 1626678
Drug: Topical anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anaesthesia with oxybuprocaine 0.4%